Showing 2511-2520 of 5956 results for "".
- Carl Zeiss Meditec and Precise Bio Announce Partnership in the Development and Commercialization of Tissue-Based Implants for Ophthalmologyhttps://modernod.com/news/carl-zeiss-meditec-and-precise-bio-announce-partnership-in-the-development-and-commercialization-of-tissue-based-implants-for-ophthalmology/2480984/Carl Zeiss Meditec and Precise Bio, a regenerative medicine company advancing the use of bio-printed tissues and organs, announced that the companies have entered into a partnership to develop and commercialize fabricated corneal tissue for transplants in patients that require endothelial ke
- Opus Genetics Expands its Leadership Teamhttps://modernod.com/news/opus-genetics-expands-its-leadership-team/2480981/Opus Genetics, a gene therapy company developing treatments for inherited retinal diseases, announced the appointments of Vikram Arora, PhD, DABT, as Vice President of Non-Clinical Development; Erin O’Neil, MD, as Vice President of Clinical Development; and Sarah Tuller, JD, RAC, as Vice Pr
- Avista Therapeutics Partners with Roche to Develop Next-Generation AAV Gene Therapy Vectors for Ocular Diseaseshttps://modernod.com/news/avista-therapeutics-partners-with-roche-to-develop-next-generation-aav-gene-therapy-vectors-for-ocular-diseases/2480977/Avista Therapeutics, which recently launched as a spinout of the University of Pittsburgh Medical Center (UPMC), announced a partnership with Roche to develop novel AAV gene therapy vectors for the eyes. The partnership aims to apply Avista’s single-cell adeno-associated
- EssilorLuxottica and Politecnico di Milano Launch Partnership to Develop Smart Glasses of the Futurehttps://modernod.com/news/essilorluxottica-and-politecnico-di-milano-launch-partnership-to-develop-smart-glasses-of-the-future/2480974/EssilorLuxottica and Politecnico di Milano have created the first joint research center aimed at designing the smart glasses of the future: EssilorLuxottica Smart Eyewear Lab. The agreement was announced today by Vittorio Colao, Minister for Technological Innovation and Digital Tra
- Apellis Presents New Phase 3 DERBY and OAKS Data of Intravitreal Pegcetacoplan for GAhttps://modernod.com/news/apellis-presents-new-phase-3-derby-and-oaks-data-of-intravitreal-pegcetacoplan-for-ga/2480970/Apellis Pharmaceuticals announced that five oral presentations and two on-demand papers are being highlighted at the American Society of Retina Specialists Annual Scientific Meeting taking place July 13 -16, 2022 in New York City. New data include
- Waldo Launches Hydra Boost Plus Lenses in the United Stateshttps://modernod.com/news/waldo-launches-hydra-boost-plus-lenses-in-the-united-states/2480962/Waldo announced the launch of Hydra Boost Plus contact lenses, now available at
- Global Data: Increasing Cataract Surgical Rates Will Drive Artificial Lenses Market to Reach $4.7 Billion by 2030https://modernod.com/news/global-data-increasing-cataract-surgical-rates-will-drive-artificial-lenses-market-to-reach-47-billion-by-2030/2480953/The global market for IOLs is forecast by GlobalData to steadily grow from $4.3 billion in 2021 to $4.7 billion by the end of the decade. The data and analytics company notes that this growth is primarily driven by the growing capacity of many hospitals and clinics across all regions to perform m
- Novartis Acquires Kedalion Therapeutics and its Ocular Delivery Platformhttps://modernod.com/news/novartis-acquires-kedalion-therapeutics-and-its-ocular-delivery-platform/2480952/Novartis announced that it has acquired Kedalion Therapeutics and its AcuStream technology, a device that may have the potential to facilitate precise dosing and accurate delivery of certain topical ophthalmic medications to the eye.1,2 Terms of the deal were
- Iveric Bio and DelSiTech Enter Exclusive Agreement for Development of Sustained Release Zimurahttps://modernod.com/news/iveric-bio-and-delsitech-enter-exclusive-agreement-for-development-of-sustained-release-zimura/2480948/Iveric bio and DelSiTech announced an exclusive global license agreement providing Iveric Bio with the right to develop and commercialize new formulations of Zimura (avacincaptad pegol) using DelSiTech’s silica-based sustained release technology. Under the terms of the l
- Efficacy of Notal Vision Home OCT Demonstrated by a Series of Scientific and Clinical Workhttps://modernod.com/news/efficacy-of-notal-vision-home-oct-demonstrated-by-a-series-of-scientific-and-clinical-work/2480942/Notal Vision reported that scientific and clinical publications and presentations demonstrate the feasibility and efficacy of their patient-operated, home-based optical coherence tomography (OCT) device. As part of a comprehensive remote monitoring service, which includes a monitoring center and